Nivolumab plus ipilimumab in second-line combination therapy for older patients with esophageal squamous cell cancer (AIO-STO-0117 trial)
Matthias Philip Ebert,Nadja M. Meindl-Beinker,Tobias Gutting,Martin Maenz,Johannes Betge,Nadine Schulte,Tianzuo Zhan,Philip Weidner,Ralf-Dieter Hofheinz,Arndt Vogel,Stefan Angermeier,Maike de Wit,Ralf Jakobs,Meinolf Karthaus,Gertraud Stocker,Peter C. Thuss-Patience,Tobias Leidig,Nicolai Haertel JOURNAL OF CLINICAL ONCOLOGY（2022）
AI 理解论文
溯源树
样例
